Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
A BioLineRx Ltd. (NASDAQ/TASE: BLRX), uma empresa biofarmacêutica de fase clínica concentrada em oncologia e imunologia, anunciou hoje que fixou o...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), empresa biofarmacéutica de etapa clínica centrada en oncología e inmunología, anunció hoy que ha fijado el precio ...
A BioLineRx Ltd. (NASDAQ/TASE: BLRX), uma empresa biofarmacêutica de fases clínicas dedicada à oncologia e à imunologia, anunciou hoje o início de...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has priced ...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), una compañía biofarmacéutica de etapa clínica centrada en la oncología y la inmunología, anunció hoy que ha...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf die Bereiche Onkologie und Immunologie...
BioLineRx Ltd. (NASDAQ/TASE : BLRX), une société biopharmaceutique au stade clinique axée sur l'oncologie et l'immunologie, a annoncé aujourd'hui...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), una compañía biofarmacéutica de etapa clínica centrada en oncología e inmunología, ha anunciado hoy que ha...
BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it has...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE:BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that the U....
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today reports its...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) (TASE: BLRX.TA), a clinical-stage biopharmaceutical company focused on oncology and immunology, today...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE:BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced top-line...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that it...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today announced that its...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today positive...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today it will...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that new...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.